Search Results

apheresis red cell exchange transfusion therapy management sickle cell disease dr paul telfer overview pathophysiology epidemiology physiological clinical considerations prior transfusion exchange transfusion indications transfusion including trials conclusions pathophysiology polymerization rbc vascular interactions depletion clinical complications acute infection e g pneumococcal dactylitis acute pain crisis apc acute chest syndrome acs aplastic crises parvovirus b19 acute splenic sequestratio

ecp cgvhd thursday 17 may 2012 bbts apheresis birmingham rotherham nhs foundation trust objectives chronic graft vs host disease photopheresis chronic graft vs host disease photopheresis economics assessments results 2 chronic gvhd key facts median onset 4 6 months 5 10 diagnosed 1yr 50 3 affected immunosuppressants required a median 2 3 years 15 still receiving 7yrs higher treatment related non relapse mortality despite lower relapse rate 12 25 ecp cgvhd owsianowski bmt 1994 14 845 848 allo sib

syphilis young irish blood donors dr louise pomeroy frcpi 17th may 2012 syphilis the great imitator he knows syphilis knows medicine lues venereum imported world columbus flaubert maupassant gaugain beethoven paganini schubert schuman syphilis caused a spirochaete treponema pallidum worldwide distribution 12 000 000 cases annually worldwide epidemiology transmission sexual contact mother child transmission vertical accidental direct inoculation blood transfusion syphilis a transfusion transmitte

rare antibodies hdn edwin massey associate medical director patient services nhsbt consultant haematologist definition occurring numbers interest value unusually remarkable structure talk definition illustrative cases resources available clinically significant antibodies ones shorten red cell survival necessarily messing compatibility tests may important ones lead symptoms signs haemolysis probably ones affect patient care argue the key questions significance antibody pregnancy mother may need a

anti a anti b titrations pilot eqa scheme megan rowley director uk neqas btlp anti a anti b titrations used clinical decision making abo incompatible solid organ transplantation abo mismatched stem cell transplantation abo hdn important accurate result why we need eqa anti a anti b titrations reliability accuracy tests used clinical decision making reinforce published guidance exists develop standard laboratory methodology support developing clinical practice work clinicians using results antibo